LoginSignup
Takeda Pharma logo

Takeda Pharma

Stock
Stock
ISIN: JP3463000004
Ticker: 4502
JP3463000004
4502

Price

Price

Historical dividends and forecast

All dividend data

Takeda Pharma has so far distributed $0.585 in 2024. The next dividend will be paid on 02.12.2024

$1.487

CHART BY

Frequently asked questions

What is Takeda Pharma's market capitalization?

The market capitalization of Takeda Pharma is $42.37B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Takeda Pharma's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Takeda Pharma is 22.66. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Takeda Pharma?

Takeda Pharma's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.176. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Takeda Pharma's stock?

Currently, 14 analysts cover Takeda Pharma's stock, with a consensus target price of $30.83. Analyst ratings provide insights into the stock's expected performance.

What is Takeda Pharma's revenue over the trailing twelve months?

Over the trailing twelve months, Takeda Pharma reported a revenue of $29.38B.

Is Takeda Pharma paying dividends?

Yes, Takeda Pharma is paying dividends. The next payment is scheduled for 02.12.2024, with an expected amount of .

What is the EBITDA for Takeda Pharma?

Takeda Pharma's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $8.40B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Takeda Pharma?

Takeda Pharma has a free cash flow of $1.56B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Takeda Pharma's stock?

The 5-year beta for Takeda Pharma is 0.91. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Takeda Pharma have, and what sector and industry does it belong to?

Takeda Pharma employs approximately 49,281 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Takeda Pharma's shares?

The free float of Takeda Pharma is 1.58B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $42.37B

5Y beta

 0.91

EPS (TTM)

 $1.176

Free Float

 1.58B

P/E ratio (TTM)

 22.66

Revenue (TTM)

 $29.38B

EBITDA (TTM)

 $8.40B

Free Cashflow (TTM)

 $1.56B

Pricing

1D span
$26.38$26.73
52W span
$25.04$30.21

Analyst Ratings

The price target is $30.83 and the stock is covered by 14 analysts.

Buy

7

Hold

7

Sell

0

Information

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

49,281

Biotechnology & Drugs

Health Care

Identifier

ISIN

JP3463000004

Primary Ticker

4502

Knockouts

Join the conversation
Sign upLogin